121 related articles for article (PubMed ID: 10918188)
1. Phosphorylation of the cytoplasmic domain of the MUC1 mucin correlates with changes in cell-cell adhesion.
Quin RJ; McGuckin MA
Int J Cancer; 2000 Aug; 87(4):499-506. PubMed ID: 10918188
[TBL] [Abstract][Full Text] [Related]
2. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
[TBL] [Abstract][Full Text] [Related]
3. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines.
Kondo K; Kohno N; Yokoyama A; Hiwada K
Cancer Res; 1998 May; 58(9):2014-9. PubMed ID: 9581847
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation.
Kato K; Lillehoj EP; Kim KC
Inflamm Res; 2016 Mar; 65(3):225-33. PubMed ID: 26645913
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
Kohlgraf KG; Gawron AJ; Higashi M; Meza JL; Burdick MD; Kitajima S; Kelly DL; Caffrey TC; Hollingsworth MA
Cancer Res; 2003 Aug; 63(16):5011-20. PubMed ID: 12941828
[TBL] [Abstract][Full Text] [Related]
6. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells.
Julian J; Carson DD
Biochem Biophys Res Commun; 2002 May; 293(4):1183-90. PubMed ID: 12054500
[TBL] [Abstract][Full Text] [Related]
7. Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail.
Wang H; Lillehoj EP; Kim KC
Biochem Biophys Res Commun; 2003 Oct; 310(2):341-6. PubMed ID: 14521915
[TBL] [Abstract][Full Text] [Related]
8. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
[TBL] [Abstract][Full Text] [Related]
9. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
[TBL] [Abstract][Full Text] [Related]
10. Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells.
Li Q; Ren J; Kufe D
Biochem Biophys Res Commun; 2004 Mar; 315(2):471-6. PubMed ID: 14766232
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinoma.
McGuckin MA; Hurst TG; Ward BG
Int J Cancer; 1995 Nov; 63(3):412-8. PubMed ID: 7591241
[TBL] [Abstract][Full Text] [Related]
12. Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.
Bernier AJ; Zhang J; Lillehoj E; Shaw AR; Gunasekara N; Hugh JC
Mol Cancer; 2011 Jul; 10():93. PubMed ID: 21798038
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules.
Zrihan-Licht S; Baruch A; Elroy-Stein O; Keydar I; Wreschner DH
FEBS Lett; 1994 Dec; 356(1):130-6. PubMed ID: 7988707
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal fluid from ovarian cancer patients stimulates MUC1 epithelial mucin expression in ovarian cancer cell lines.
Munster DJ; Quin RJ; Bansal AS; Ward BG; McGuckin MA
Int J Cancer; 1998 May; 76(3):393-8. PubMed ID: 9579577
[TBL] [Abstract][Full Text] [Related]
15. The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein.
Baruch A; Hartmann M; Yoeli M; Adereth Y; Greenstein S; Stadler Y; Skornik Y; Zaretsky J; Smorodinsky NI; Keydar I; Wreschner DH
Cancer Res; 1999 Apr; 59(7):1552-61. PubMed ID: 10197628
[TBL] [Abstract][Full Text] [Related]
16. The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer.
Regimbald LH; Pilarski LM; Longenecker BM; Reddish MA; Zimmermann G; Hugh JC
Cancer Res; 1996 Sep; 56(18):4244-9. PubMed ID: 8797599
[TBL] [Abstract][Full Text] [Related]
17. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
Khodarev N; Ahmad R; Rajabi H; Pitroda S; Kufe T; McClary C; Joshi MD; MacDermed D; Weichselbaum R; Kufe D
Oncogene; 2010 Feb; 29(6):920-9. PubMed ID: 19915608
[TBL] [Abstract][Full Text] [Related]
18. Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways.
Thompson EJ; Shanmugam K; Hattrup CL; Kotlarczyk KL; Gutierrez A; Bradley JM; Mukherjee P; Gendler SJ
Mol Cancer Res; 2006 Jul; 4(7):489-97. PubMed ID: 16849524
[TBL] [Abstract][Full Text] [Related]
19. The cytoplasmic tail of MUC1: a very busy place.
Carson DD
Sci Signal; 2008 Jul; 1(27):pe35. PubMed ID: 18612140
[TBL] [Abstract][Full Text] [Related]
20. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.
Ricardo S; Marcos-Silva L; Pereira D; Pinto R; Almeida R; Söderberg O; Mandel U; Clausen H; Felix A; Lunet N; David L
Mol Oncol; 2015 Feb; 9(2):503-12. PubMed ID: 25454345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
